Modeling the effect of tat inhibitors on HIV latency
- 17 April 2019
- journal article
- research article
- Published by Elsevier in Journal of Theoretical Biology
- Vol. 473, 20-27
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Strategies to Block HIV Transcription: Focus on Small Molecule Tat InhibitorsBiology, 2012
- The Viral Protein Tat Can Inhibit the Establishment of HIV-1 LatencyJournal of Virology, 2012
- Inhibition of Tat-mediated HIV-1 replication and neurotoxicity by novel GSK3-beta inhibitorsVirology, 2011
- Cellular Decision Making and Biological Noise: From Microbes to MammalsCell, 2011
- Mapping the architecture of the HIV-1 Tat circuit: A decision-making circuit that lacks bistability and exploits stochastic noiseMethods, 2011
- Dominant negative mutant Cyclin T1 proteins inhibit HIV transcription by specifically degrading TatRetrovirology, 2008
- Low-level viremia persists for at least 7 years in patients on suppressive antiretroviral therapyProceedings of the National Academy of Sciences, 2008
- Inhibition of HIV-1 replication by P-TEFb inhibitors DRB, seliciclib and flavopiridol correlates with release of free P-TEFb from the large, inactive form of the complexRetrovirology, 2007
- COPASI—a COmplex PAthway SImulatorBioinformatics, 2006
- Quantification of latent tissue reservoirs and total body viral load in HIV-1 infectionNature, 1997